DC Circ. Affirms FDA Can Block Norwich's IBS Generic
The D.C. Circuit on Friday backed the U.S. Food and Drug Administration's lower court win in Norwich Pharmaceuticals' challenge to the agency's refusal to approve an application to bring a generic...To view the full article, register now.
Already a subscriber? Click here to view full article